Literature DB >> 11526143

Group G beta-hemolytic streptococcal bacteremia characterized by 16S ribosomal RNA gene sequencing.

P C Woo1, A M Fung, S K Lau, S S Wong, K Y Yuen.   

Abstract

Little is known about the relative importance of the four species of Lancefield group G beta-hemolytic streptococci in causing bacteremia and the factors that determine the outcome for patients with group G beta-hemolytic streptococcal bacteremia. From 1997 to 2000, 75 group G beta-hemolytic streptococcal strains were isolated from the blood cultures of 66 patients. Sequencing of the 16S rRNA genes of the group G beta-hemolytic streptococci showed that all 75 isolates were Streptococcus dysgalactiae subspecies equisimilis. The API system (20 STREP) and Vitek system (GPI) successfully identified 65 (98.5%) and 62 (93.9%) isolates, respectively, as S. dysgalactiae subspecies equisimilis with >95% confidence, whereas the ATB Expression system (ID32 STREP) only successfully identified 49 isolates (74.2%) as S. dysgalactiae subspecies equisimilis with >95% confidence. The median age of the patients was 76 years (range, 33 to 99 years). Fifty-six patients (85%) were over 60 years old. All patients had underlying diseases. No source of the bacteremia was identified (primary bacteremia) in 34 patients (52%), whereas 17 (26%) had cellulitis and 8 (12%) had bed sore or wound infections. Fifty-eight patients (88%) had community-acquired group G streptococcal bacteremia. Sixty-two patients (94%) had group G Streptococcus recovered in one blood culture, whereas 4 patients (6%) had it recovered in multiple blood cultures. Fifty-nine patients (89%) had group G Streptococcus as the only bacterium recovered in their blood cultures, whereas in 7 patients other bacteria were recovered concomitantly with the group G Streptococcus in the blood cultures (Staphylococcus aureus in 3, Clostridium perfringens in 2, Citrobacter freundii in 1, and Bacteroides fragilis in 1). Overall, 10 patients (15%) died. Male sex, diagnosis other than cellulitis, hospital-acquired bacteremia, and multiple positive blood cultures were associated with mortality [P < 0.005 (relative risk [RR] = 7.6), P < 0.05 (RR = 3.7), P < 0.005 (RR = 5.6), and P < 0.05 (RR = 5.6), respectively]. Unlike group C beta-hemolytic streptococcal bacteremia, group G beta-hemolytic streptococcal bacteremia is not a zoonotic infection in Hong Kong.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11526143      PMCID: PMC88311          DOI: 10.1128/JCM.39.9.3147-3155.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Cellulitis complicating lymphoedema.

Authors:  P C Woo; P N Lum; S S Wong; V C Cheng; K Y Yuen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-04       Impact factor: 3.267

2.  Nucleotide sequence of the erythromycin resistance gene of the conjugative transposon Tn1545.

Authors:  P Trieu-Cuot; C Poyart-Salmeron; C Carlier; P Courvalin
Journal:  Nucleic Acids Res       Date:  1990-06-25       Impact factor: 16.971

3.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

4.  Group G streptococcal septicaemia: clinical observations and laboratory studies.

Authors:  R G Finch; A Aveline
Journal:  J Infect       Date:  1984-09       Impact factor: 6.072

Review 5.  Origin and evolution of genes specifying resistance to macrolide, lincosamide and streptogramin antibiotics: data and hypotheses.

Authors:  M Arthur; A Brisson-Noël; P Courvalin
Journal:  J Antimicrob Chemother       Date:  1987-12       Impact factor: 5.790

Review 6.  Beta-haemolytic group A, B, C and G streptococcal septicaemia: a clinical study.

Authors:  K Skogberg; H Simonen; O V Renkonen; V V Valtonen
Journal:  Scand J Infect Dis       Date:  1988

Review 7.  Streptococcus zooepidemicus (Lancefield group C) septicaemia in Hong Kong.

Authors:  K Y Yuen; W H Seto; C H Choi; W Ng; S W Ho; P Y Chau
Journal:  J Infect       Date:  1990-11       Impact factor: 6.072

8.  Group G streptococcal bacteremia. The clinical experience at Boston University Medical Center and a critical review of the literature.

Authors:  K L Watsky; N Kollisch; P Densen
Journal:  Arch Intern Med       Date:  1985-01

9.  Unique risk factors for bacteraemia in allogeneic bone marrow transplant recipients before and after engraftment.

Authors:  K Y Yuen; P C Woo; C H Hui; W K Luk; F E Chen; A K Lie; R Liang
Journal:  Bone Marrow Transplant       Date:  1998-06       Impact factor: 5.483

10.  A complex attenuator regulates inducible resistance to macrolides, lincosamides, and streptogramin type B antibiotics in Streptococcus sanguis.

Authors:  S Horinouchi; W H Byeon; B Weisblum
Journal:  J Bacteriol       Date:  1983-06       Impact factor: 3.490

View more
  37 in total

1.  Usefulness of the MicroSeq 500 16S ribosomal DNA-based bacterial identification system for identification of clinically significant bacterial isolates with ambiguous biochemical profiles.

Authors:  Patrick C Y Woo; Kenneth H L Ng; Susanna K P Lau; Kam-tong Yip; Ami M Y Fung; Kit-wah Leung; Dorothy M W Tam; Tak-lun Que; Kwok-yung Yuen
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

2.  Continuous ambulatory peritoneal dialysis-related peritonitis associated with Lancefield group G beta-hemolytic streptococcus: report of two cases requiring Tenckhoff catheter removal.

Authors:  Patrick C Y Woo; Samson S Y Wong; Susanna K P Lau; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

Review 3.  Streptococcus dysgalactiae subsp. equisimilis bacteremia: an emerging infection.

Authors:  S Rantala
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-29       Impact factor: 3.267

4.  Clonal relationships between invasive and noninvasive Lancefield group C and G streptococci and emm-specific differences in invasiveness.

Authors:  M D Pinho; J Melo-Cristino; M Ramirez
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

5.  Gemella bacteraemia characterised by 16S ribosomal RNA gene sequencing.

Authors:  P C Y Woo; S K P Lau; A M Y Fung; S K Chiu; R W H Yung; K Y Yuen
Journal:  J Clin Pathol       Date:  2003-09       Impact factor: 3.411

6.  First report of brain abscess caused by a satelliting phenotypic variant of Helcococcus kunzii.

Authors:  Siddharth Sridhar; Jasper F W Chan; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2013-10-30       Impact factor: 5.948

7.  Gordonia species as emerging causes of continuous-ambulatory-peritoneal-dialysis-related peritonitis identified by 16S rRNA and secA1 gene sequencing and matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS).

Authors:  Jimmy Y W Lam; Alan K L Wu; Wai-Shing Leung; Ingrid Cheung; Chi-Ching Tsang; Jonathan H K Chen; Jasper F W Chan; Cindy W S Tse; Rodney A Lee; Susanna K P Lau; Patrick C Y Woo
Journal:  J Clin Microbiol       Date:  2014-11-26       Impact factor: 5.948

8.  Analysis of a viridans group strain reveals a case of bacteremia due to lancefield group G alpha-hemolytic Streptococcus dysgalactiae subsp equisimilis in a patient with pyomyositis and reactive arthritis.

Authors:  Patrick C Y Woo; Jade L L Teng; Susanna K P Lau; Peggy N L Lum; Kit-Wah Leung; Kee-Lam Wong; Kin-Wah Li; Kui-Chun Lam; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

9.  Population genetics of Streptococcus dysgalactiae subspecies equisimilis reveals widely dispersed clones and extensive recombination.

Authors:  David J McMillan; Debra E Bessen; Marcos Pinho; Candace Ford; Gerod S Hall; José Melo-Cristino; Mário Ramirez
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

10.  Increase in group G streptococcal infections in a community hospital, New York, USA.

Authors:  San S Wong; Yu S Lin; Liby Mathew; Latha Rajagopal; Douglas Sepkowitz
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.